Fast Track to Fertility for Infertility
(FTFRCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how the Fast Track to Fertility Algorithmic Text Messaging Platform can accelerate infertility diagnosis. The platform sends personalized text prompts and educational videos on topics such as fertility tests, nutrition, and lifestyle changes. It targets new female patients at Penn Fertility Care who have not completed at least three key components of their fertility testing, such as blood tests or pelvic ultrasounds. Participants will be randomly assigned to use either the new platform or the standard information materials. As an unphased trial, this study provides participants the chance to contribute to innovative research that could improve fertility care for future patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for improving fertility workup efficiency?
Research shows that the Fast Track to Fertility program uses text messages and videos to help people understand and complete fertility tests more quickly. The program involves no new medicines or medical procedures, so typical drug-related safety concerns, such as side effects, do not apply.
The main goal is to enhance communication and education for patients through digital tools. As it serves as a platform for sharing information rather than a medical treatment, safety risks remain very low. Participants receive messages and video links about fertility topics to aid in making informed decisions.
In simpler terms, joining this program is like using a health app that guides users through fertility issues. It focuses on providing information and reminders to support the fertility journey. Current research shows no safety risks associated with using this type of platform.12345Why are researchers excited about this trial?
Researchers are excited about the Fast Track to Fertility Algorithmic Text Messaging Platform because it offers a personalized and interactive approach to fertility treatment. Unlike the traditional standard of care, which involves static printed or electronic materials, this platform uses algorithm-driven text messaging to guide patients through next steps and provide tailored educational content. It also includes engaging video links on crucial topics like menstrual cycles, nutrition, and mental health, potentially enhancing patient understanding and engagement. By leveraging technology to deliver timely and relevant information, this method aims to empower patients and optimize their fertility journey.
What evidence suggests that the Fast Track to Fertility program is effective for improving fertility workup efficiency?
Research has shown that the Fast Track to Fertility (FTF) program, which participants in this trial may receive, can significantly speed up the fertility testing process. Early results found that the program halved the time needed for diagnostic tests. Patients moved from their first appointment to starting treatment much faster, reducing the wait from over two months to just 41 days. The program uses text messages to remind patients about tests and share educational materials. These features help patients learn more and take charge of their care, making the process more efficient.12346
Who Is on the Research Team?
Anuja Dokras, MD, MHCI, PhD
Principal Investigator
University of Pennsylvania
Are You a Good Fit for This Trial?
The Fast Track to Fertility trial is for individuals experiencing infertility who are undergoing a fertility workup. The study aims to include participants willing to use an algorithmic text messaging platform with educational videos designed to expedite and enhance their diagnostic process.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Diagnostic Work-up
Participants undergo a personalized fertility diagnostic work-up including laboratory tests, imaging, and genetic screening
Treatment Initiation
Participants begin fertility treatment based on diagnostic work-up results
Follow-up
Participants are monitored for treatment effectiveness and pregnancy outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Fast Track to Fertility Algorithmic Text Messaging Platform
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Ferring Pharmaceuticals
Industry Sponsor
Pierre-Yves Berclaz
Ferring Pharmaceuticals
Chief Medical Officer since 2023
MD from the University of Lausanne, PhD in Molecular Biology from the Cincinnati College of Medicine
Jean-Frédéric Paulsen
Ferring Pharmaceuticals
Chief Executive Officer since 2023
Master’s degree in Finance from the London School of Economics and Political Science